dapi has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
DAPI: RN given refers to parent cpd.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tremblay, ME | 1 |
| Saint-Pierre, M | 1 |
| Bourhis, E | 1 |
| Lévesque, D | 1 |
| Rouillard, C | 1 |
| Cicchetti, F | 1 |
| Deguil, J | 1 |
| Jailloux, D | 1 |
| Page, G | 1 |
| Fauconneau, B | 1 |
| Houeto, JL | 1 |
| Philippe, M | 1 |
| Muller, JM | 1 |
| Pain, S | 1 |
2 other studies available for dapi and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Neuroprotective effects of cystamine in aged parkinsonian mice.
Topics: Aging; Animals; Cell Count; Corpus Striatum; Cystamine; Disease Models, Animal; Dopamine Plasma Memb | 2006 |
Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP+-induced alteration of translational control in Neuro-2a neuroblastoma cells.
Topics: Animals; Blotting, Western; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Fluorescent Dyes; Indoles; | 2007 |